Medical Director MGB Sports Medicine
MGB/Harvard
Andover, MA, US
Augustus (Gus) D. Mazzocca, MS, MD, FAAOS, FAOA was appointed the Director of Mass General Brigham Sports Medicine Enterprise, Chief of MGH Sports Medicine, and Director of MGH Sports Bioskills, Biomechanics and Cell Biology Laboratories for the Department of Orthopaedic Surgery at The Massachusetts General Hospital (MGH) in May of 2022. Prior to joining the Department of Orthopaedic Surgery at MGH. Dr Mazzocca earned his BS in Biology from Denison University, MS in Applied Physiology from Springfield College, his MD from University of Connecticut School of Medicine. He completed an internship and residency with the Department of Orthopaedic Surgery at the University of Connecticut School of Medicine. He completed a Fellowship in Sports, Shoulder and Elbow Surgery at RUSH University in Chicago IL.
Dr. Mazzocca has dedicated his non-clinical life to education, research and his family, which is most important to him. He is a member of the prestigious American Orthopaedic Society for Sports Medicine (AOSSM), American Shoulder and Elbow Surgeons Society (ASES), The International Society of Arthroscopy, Knee Surgery and Orthopedic Sports medicine (ISAKOS), as well as being a member of the European Society for Surgery of the Shoulder and Elbow (ESSSE). He and colleague Jon J.P. Warner, MD, co-founded the New England Shoulder and Elbow Society (NESES), which is a regional society dedicated to educating and researching problems related to the shoulder and elbow.
IC06- Practice Surgical Augmentation Rotator Cuff Repair using Biologics
Saturday, July 11, 2026
8:30 AM - 9:30 AM PDT
Disclosure(s): Arthrex, Inc: Consultant (Ongoing), Researcher (Ongoing); restor3d: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing)
Introduction and Perioperative Optimization
Saturday, July 11, 2026
8:30 AM - 8:38 AM PDT
Disclosure(s): Arthrex, Inc: Consultant (Ongoing), Researcher (Ongoing); restor3d: Consultant (Ongoing), Own stock options in a privately held ineligible company (Ongoing)